Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Biosoftware 'Business as Usual' Despite Merck's Restructuring

NEW YORK (GenomeWeb News) – Merck’s Rosetta Biosoftware unit will be unaffected by the pharma giant’s recently announced restructuring, a Rosetta spokesperson told GenomeWeb Daily News today.
 
In late October, Merck announced plans to lay off 7,200 employees worldwide and to close basic research sites in Tsukuba, Japan; Pomezia, Italy; and Seattle. The Seattle site is the home of Rosetta Inpharmatics, which Merck acquired in 2001 for $620 million. Since then, the Rosetta group has primarily served a research function for Merck, with the exception of the software business, which operated as a separate unit under the name of Rosetta Biosoftware.
 
Merck plans to move around 100 of the 300 Rosetta Inpharmatics employees to its research center in Boston, but Rosetta Biosoftware, which employs 60 people, plans on staying put, according to Kristen Stoops, senior director of marketing and alliances at Rosetta Biosoftware.
 
“It’s business as usual” for the software unit, Stoops said. “There has been no impact on our daily business operations, nor do we foresee any impact.”
 
Stoops said that there are no plans to relocate the software business, which will continue to operate “unaltered” despite the changes planned for the Rosetta Inpharmatics group.
 
Stoops acknowledged that there is a possibility that Merck may spin out Rosetta Biosoftware as an independent entity, but she noted that that option has “always been on the table” for the bioinformatics business.  

Filed under

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.